Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Ani Pharmaceuticals (ANIP) Return on Sales: 2010-2024

Historic Return on Sales for Ani Pharmaceuticals (ANIP) over the last 15 years, with Dec 2024 value amounting to -0.03%.

  • Ani Pharmaceuticals' Return on Sales rose 6.00% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.05%, marking a year-over-year increase of 6.00%. This contributed to the annual value of -0.03% for FY2024, which is 7.00% down from last year.
  • According to the latest figures from FY2024, Ani Pharmaceuticals' Return on Sales is -0.03%, which was down 178.15% from 0.04% recorded in FY2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Sales peaked at 0.04% during FY2023, and registered a low of -0.20% during FY2021.
  • Over the past 3 years, Ani Pharmaceuticals' median Return on Sales value was -0.03% (recorded in 2024), while the average stood at -0.05%.
  • In the last 5 years, Ani Pharmaceuticals' Return on Sales fell by 16bps in 2020 and then climbed by 19bps in 2023.
  • Over the past 5 years, Ani Pharmaceuticals' Return on Sales (Yearly) stood at -0.17% in 2020, then dropped by 3bps to -0.20% in 2021, then increased by 5bps to -0.15% in 2022, then grew by 19bps to 0.04% in 2023, then dropped by 7bps to -0.03% in 2024.